No. 21-406
 
Title: Impax Laboratories, Inc., Petitioner
v.
Federal Trade Commission
Docketed: September 15, 2021
Lower Ct: United States Court of Appeals for the Fifth Circuit
   Case Numbers: (19-60394)
   Decision Date: April 13, 2021
 
Proceedings and Orders
Sep 10 2021 Petition for a writ of certiorari filed. (Response due October 15, 2021)
Petition Appendix Certificate of Word Count Proof of Service
Oct 05 2021 Motion to extend the time to file a response from October 15, 2021 to November 15, 2021, submitted to The Clerk.
Main Document
Oct 06 2021 Motion to extend the time to file a response is granted and the time is extended to and including November 15, 2021.
Oct 15 2021 Brief amicus curiae of Association for Accessible Medicines filed.
Main Document Certificate of Word Count Proof of Service Other
Nov 15 2021 Brief of respondent Federal Trade Commission in opposition filed.
Main Document Proof of Service
Nov 22 2021 Waiver of the 14-day waiting period under 15.5 filed.
Main Document
Nov 23 2021 DISTRIBUTED for Conference of 12/10/2021.
Nov 23 2021 Reply of Impax Laboratories, Inc. not accepted for filing. (November 23, 2021)
Nov 23 2021 Reply of petitioner Impax Laboratories, Inc. filed. (Distributed)
Main Document Certificate of Word Count Proof of Service
Dec 13 2021 Petition DENIED.
Attorneys
Attorneys for Petitioners
Jay Philip Lefkowitz
Counsel of Record
Kirkland & Ellis LLP
601 Lexington Ave.
New York, NY 10022

lefkowitz@kirkland.com
Ph: (212) 446-4800
Party name: Impax Laboratories, Inc.


Attorneys for Respondents
Elizabeth B. Prelogar
Counsel of Record
Solicitor General
United States Department of Justice
950 Pennsylvania Avenue, NW
Washington, DC 20530-0001

SUPREMECTBRIEFS@USDOJ.GOV
Ph: 202-514-2217
Party name: United States


Other Attorneys
Brian Timothy Burgess
Counsel of Record
Goodwin Procter, LLP
1900 N Street, N.W.
Washington, DC 20036

BBurgess@goodwinlaw.com
Ph: 2023464000
Party name: Association for Accessible Medicines